“…6,7 Shortlisting dupilumab as an anti-wart remedy would, therefore, be welcomed news for patients and doctors (and the manufacturer) alike. In fact, two other cases of cutaneous 8 or genital 9 warts and seven cases of disseminated molluscum, [10][11][12][13] which cleared in AD patients undergoing dupilumab therapy, were reported previously.…”